Showing results (1831-1840 of 3,323) with videos related to

Sort By:
Pageof 333
Microbiology (Reading, England)|October 1, 1996
Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15FT J Coffey, S Berrón, M Daniels, et al.
Biomed Research International|October 2, 2015
Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular AdnexaOmbretta Annibali, Francesca Chiodi, Chiara Sarlo, et al.
World Journal of Gastrointestinal Oncology|October 2, 2020
Colorectal cancer metastatic to the breast: A case reportSilvia Taccogna, Elisa Gozzi, Luigi Rossi, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|January 6, 2021
Baseline characteristics of COVID-19 Italian patients admitted to Desio Hospital, Lombardy: a retrospective studyAdela Sulejmani, Elisa Galimberti, Chiara Giacobone, et al.
Physics in Medicine and Biology|January 6, 2025
Generalized, sublethal damage-based mathematical approach for improved modeling of clonogenic survival curve flattening upon hyperthermia, radiotherapy, and beyondAdriana M De Mendoza, Soňa Michlíková, Paula S Castro, et al.
Veterinaria Italiana|February 20, 2024
Does a therapeutical dose of ivermectin impairs testicular homeostasis of rats via excessive apoptosis?Flora Cordeiro, Flaviane L Ceglio, Nathalia A Galvão, et al.
Annals of the Rheumatic Diseases|November 18, 2023
OA susceptibility in mice is partially mediated by the gut microbiome, is transferrable via microbiome transplantation and is associated with immunophenotype changesEmmaline Prinz, Leoni Schlupp, Gabby Dyson, et al.
Geroscience|November 9, 2023
Murine cartilage microbial DNA deposition occurs rapidly following the introduction of a gut microbiome and changes with obesity, aging, and knee osteoarthritisVladislav Izda, Leoni Schlupp, Emmaline Prinz, et al.
Cancer Research|October 5, 2001
Biochemical genetic analysis of indanocine resistance in human leukemiaX H Hua, D Genini, R Gussio, et al.
Anti-Cancer Drug Design|November 22, 2001
Imidazo[2,1 -b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibitionA Andreani, A Cavalli, M Granaiola, et al.
Pageof 333